منابع مشابه
BCG Vaccination
BCG VACCINATION. Studies by the WHO Tuberculosis Research Office, Copenhagen. Report prepared under the direction of Lydia B. Edwards and Carroll E. Palmer with the assistance of Knut Magnus. Monograph Series No. 12. Geneva, World Health Organization, 1953. 307 pp. 15/-, $3.00, Sw. fr. 12.This monograph contains the results of an inquiry into the variable factors that affect BCG vaccination. Th...
متن کاملSystemic BCG‐osis following intravesical BCG instillation for bladder carcinoma
Intravesical instillation of Bacillus Calmette-Guérin (BCG) has been shown to be an effective form of immunotherapy for bladder cancer. This case report describes a patient who develops systemic BCG-osis following intravesical BCG instillation and demonstrates the importance of being aware of more severe complications associated with BCG immunotherapy.
متن کاملBCG lymphadenopathy detected in a BCG-vaccinated infant.
Large-scale vaccination with BCG, the live attenuated strain of Mycobacterium bovis, is being adopted around the world, although sporadic complications have occurred after the procedure. Lymphadenopathy is not uncommon especially in babies under one year (0.73% of vaccinated infants), but the swelling subsides within 2 months in most cases, with no medical or surgical treatment. Brazil adopted ...
متن کاملThe BCG Shortage
In 2014, I was on the Board of Directors of the Society of Urologic Oncology (SUO) when Merck announced having shortages of Tice strain Bacillus Calmette Guerin (BCG), a critical “drug” for treating intermediate and particularly high risk non-muscle invasive (NMI) urothelial cancer (UC) of the bladder, including carcinoma-in-situ (CIS) and high-grade (HG), stage Ta and T1 disease after transure...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Reactions Weekly
سال: 2021
ISSN: ['1179-2051', '0114-9954']
DOI: https://doi.org/10.1007/s40278-021-03326-5